165 related articles for article (PubMed ID: 23959425)
1. CrkL efficiently mediates cell proliferation, migration, and invasion induced by TGF-β pathway in glioblastoma.
Lv S; Qin J; Yi R; Coreman M; Shi R; Kang H; Yao C
J Mol Neurosci; 2013 Nov; 51(3):1046-51. PubMed ID: 23959425
[TBL] [Abstract][Full Text] [Related]
2. Nucleolin promotes TGF-β signaling initiation via TGF-β receptor I in glioblastoma.
Lv S; Zhang J; Han M; Wang W; Zhang Y; Zhuang D; Shi R; Bian R; Yao C
J Mol Neurosci; 2015 Jan; 55(1):1-6. PubMed ID: 24682943
[TBL] [Abstract][Full Text] [Related]
3. Crk-like adapter protein is required for TGF-β-induced AKT and ERK-signaling pathway in epithelial ovarian carcinomas.
Cheng S; Guo J; Yang Q; Han L
Tumour Biol; 2015 Feb; 36(2):915-9. PubMed ID: 25307974
[TBL] [Abstract][Full Text] [Related]
4. Quantitative assessment of glioblastoma phenotypes in vitro establishes cell migration as a robust readout of Crk and CrkL activity.
Park T; Large N; Curran T
J Biol Chem; 2021; 296():100390. PubMed ID: 33561443
[TBL] [Abstract][Full Text] [Related]
5. The Downregulation of MicroRNA-146a Modulates TGF-β Signaling Pathways Activity in Glioblastoma.
Lv S; Sun B; Dai C; Shi R; Zhou X; Lv W; Zhong X; Wang R; Ma W
Mol Neurobiol; 2015 Dec; 52(3):1257-1262. PubMed ID: 25326894
[TBL] [Abstract][Full Text] [Related]
6. Crk-like adapter protein regulates CCL19/CCR7-mediated epithelial-to-mesenchymal transition via ERK signaling pathway in epithelial ovarian carcinomas.
Cheng S; Guo J; Yang Q; Yang X
Med Oncol; 2015 Mar; 32(3):47. PubMed ID: 25636509
[TBL] [Abstract][Full Text] [Related]
7. CrkL regulates SDF-1-induced breast cancer biology through balancing Erk1/2 and PI3K/Akt pathways.
Lian X; Jiao Y; Yang Y; Wang Z; Xuan Q; Liu H; Lu S; Wang Z; Liu Y; Li S; Yang Y; Guo L; Zhao L; Zhang Q
Med Oncol; 2015 Jan; 32(1):411. PubMed ID: 25476480
[TBL] [Abstract][Full Text] [Related]
8. CRKL overexpression suppresses in vitro proliferation, invasion and migration of murine hepatocarcinoma Hca-P cells.
Lin Q; Sun MZ; Guo C; Shi J; Chen X; Liu S
Biomed Pharmacother; 2015 Feb; 69():11-7. PubMed ID: 25661331
[TBL] [Abstract][Full Text] [Related]
9. CrkL meditates CCL20/CCR6-induced EMT in gastric cancer.
Han G; Wu D; Yang Y; Li Z; Zhang J; Li C
Cytokine; 2015 Dec; 76(2):163-169. PubMed ID: 26044596
[TBL] [Abstract][Full Text] [Related]
10. MAP kinase-interacting kinase 1 regulates SMAD2-dependent TGF-β signaling pathway in human glioblastoma.
Grzmil M; Morin P; Lino MM; Merlo A; Frank S; Wang Y; Moncayo G; Hemmings BA
Cancer Res; 2011 Mar; 71(6):2392-402. PubMed ID: 21406405
[TBL] [Abstract][Full Text] [Related]
11. CRKL knockdown promotes in vitro proliferation, migration and invasion, in vivo tumor malignancy and lymph node metastasis of murine hepatocarcinoma Hca-P cells.
Shi J; Meng L; Sun MZ; Guo C; Sun X; Lin Q; Liu S
Biomed Pharmacother; 2015 Apr; 71():84-90. PubMed ID: 25960220
[TBL] [Abstract][Full Text] [Related]
12. β-Elemene inhibits proliferation through crosstalk between glia maturation factor β and extracellular signal‑regulated kinase 1/2 and impairs drug resistance to temozolomide in glioblastoma cells.
Zhu TZ; Li XM; Luo LH; Xu YH; Cao P; Liu Y; Liang GB
Mol Med Rep; 2014 Aug; 10(2):1122-8. PubMed ID: 24866280
[TBL] [Abstract][Full Text] [Related]
13. ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells.
Zhong J; Gencay MM; Bubendorf L; Burgess JK; Parson H; Robinson BW; Tamm M; Black JL; Roth M
J Cell Physiol; 2006 May; 207(2):540-52. PubMed ID: 16447244
[TBL] [Abstract][Full Text] [Related]
14. Fucoxanthin Activates Apoptosis via Inhibition of PI3K/Akt/mTOR Pathway and Suppresses Invasion and Migration by Restriction of p38-MMP-2/9 Pathway in Human Glioblastoma Cells.
Liu Y; Zheng J; Zhang Y; Wang Z; Yang Y; Bai M; Dai Y
Neurochem Res; 2016 Oct; 41(10):2728-2751. PubMed ID: 27394418
[TBL] [Abstract][Full Text] [Related]
15. Suppression of A549 cell proliferation and metastasis by calycosin via inhibition of the PKC‑α/ERK1/2 pathway: An in vitro investigation.
Cheng XD; Gu JF; Yuan JR; Feng L; Jia XB
Mol Med Rep; 2015 Dec; 12(6):7992-8002. PubMed ID: 26498639
[TBL] [Abstract][Full Text] [Related]
16. The effects of Micro-429 on inhibition of cervical cancer cells through targeting ZEB1 and CRKL.
Wang Y; Dong X; Hu B; Wang XJ; Wang Q; Wang WL
Biomed Pharmacother; 2016 May; 80():311-321. PubMed ID: 27133071
[TBL] [Abstract][Full Text] [Related]
17. miR-429-CRKL axis regulates clear cell renal cell carcinoma malignant progression through SOS1/MEK/ERK/MMP2/MMP9 pathway.
Wang J; Wang C; Li Q; Guo C; Sun W; Zhao D; Jiang S; Hao L; Tian Y; Liu S; Sun MZ
Biomed Pharmacother; 2020 Jul; 127():110215. PubMed ID: 32413671
[TBL] [Abstract][Full Text] [Related]
18. CRKL protein overexpression enhances cell proliferation and invasion in pancreatic cancer.
Fu L; Dong Q; Xie C; Wang Y; Li Q
Tumour Biol; 2015 Feb; 36(2):1015-22. PubMed ID: 25318601
[TBL] [Abstract][Full Text] [Related]
19. Amphiregulin promotes trophoblast invasion and increases MMP9/TIMP1 ratio through ERK1/2 and Akt signal pathways.
Yu Y; Fang L; Wang S; Li Y; Guo Y; Sun YP
Life Sci; 2019 Nov; 236():116899. PubMed ID: 31614145
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of CRKL correlates with malignant cell proliferation in breast cancer.
Zhao T; Miao Z; Wang Z; Xu Y; Wu J; Liu X; You Y; Li J
Tumour Biol; 2013 Oct; 34(5):2891-7. PubMed ID: 23686806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
